Cita APA

Puente, J., Lainez, N., Dueñas, M., Méndez-Vidal, M. J., Esteban, E., Castellano, D., . . . Group), S. (. O. G. (2017). Novel potential predictive markers of sunitinib outcomes in long-term responders versus primary refractory patients with metastatic clear-cell renal cell carcinoma.

Citación estilo Chicago

Puente, Javier, et al. Novel Potential Predictive Markers of Sunitinib Outcomes in Long-term Responders Versus Primary Refractory Patients With Metastatic Clear-cell Renal Cell Carcinoma. 2017.

Cita MLA

Puente, Javier, et al. Novel Potential Predictive Markers of Sunitinib Outcomes in Long-term Responders Versus Primary Refractory Patients With Metastatic Clear-cell Renal Cell Carcinoma. 2017.